Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia - Related Studies

Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia

This study is currently recruiting participants.

Study NCT00330551. Last updated on January 4, 2008. Information provided by National Institute of Mental Health (NIMH)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Schizophrenia

2	More general conditions related to this trial
		Mental Disorders
		Schizophrenia and Disorders with Psychotic Features

3	Interventions listed in this trial
		Individual Case Management
		Oral Risperidone

4	Additional drug interventions recognized in this trial
		Risperidone

5	More general drug interventions related to this trial
		Antipsychotic Agents
		Central Nervous System Agents
		Central Nervous System Depressants
		Dopamine Agents
		Dopamine Antagonists
		Molecular Mechanisms of Pharmacological Action
		Neurotransmitter Agents
		Pharmacologic Actions
		Physiological Effects of Drugs
		Psychotropic Drugs
		Serotonin Agents
		Serotonin Antagonists
		Therapeutic Uses
		Tranquilizing Agents

6	Sponsors listed in this trial
		National Institute of Mental Health (NIMH)